Aplagon doses first patient in phase 2a trial of APAC with peripheral arterial occlusive disease/chronic limb threatening ischemia: Helsinki, Finland Saturday, March 14, 2026, 18: ...
Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...
Greenwood Leflore Hospital welcomed doctors from Guatemala last week to provide education and training that will help save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results